Skip to main content
Erschienen in: Urolithiasis 3/2014

01.06.2014 | Original Paper

In vitro encrustation of a semi-permanent polymer-covered nitinol ureter stent: an artificial urine model

verfasst von: Tabassum Shaheen, Thiaga Edirisinghe, Melissa Gabriel, Andreas Bourdoumis, Noor Buchholz, Martin Knight

Erschienen in: Urolithiasis | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To measure and compare the percentage of surface and luminal thickness of encrustation in Allium and conventional double J ureteric stents after exposure for 6 weeks to an accelerated encrustation model.

Material and Methods

An artificial urine solution was prepared and three stents were immersed into each of six containers allocated to each stent type, representing each week of encrustation. Slight agitation was accomplished by placing a magnetic stirrer at the bottom of each container. Images were obtained by examination under a stereomicroscope and analyzed with the aid of specialized image analysis software (Image J).

Results

By week 2, nearly 100 % of the stent surface was covered by a thin layer of encrustation, gradually increasing in thickness through weeks 3–6. On completion of 6 weeks of encrustation, the 10 mm length double J stent specimens did not show visible encrustation, while the 60 mm long Allium stents showed 100 % surface coverage. This was most evident in the mid-section of the stents compared to the ends, suggesting a correlation between stent length and encrustation formation. There was also no blockage of the lumen of either stents between weeks 1–6.

Conclusion

The designed accelerated encrustation model was successful and showed 80 % surface coverage after 6 weeks. In our study, there appears to be a slightly reduced level of surface encrustation to that of earlier reports. A correlation between stent length and geometry was suggested. This model may be used to compare encrustation for a variety of polymeric stent materials.
Literatur
1.
Zurück zum Zitat Cox AJ, Harries JE, Hukins DW, Kennedy AP, Sutton TM (1987) Calcium phosphate in catheter encrustation. Br J Urol 59(2):159–163PubMedCrossRef Cox AJ, Harries JE, Hukins DW, Kennedy AP, Sutton TM (1987) Calcium phosphate in catheter encrustation. Br J Urol 59(2):159–163PubMedCrossRef
2.
Zurück zum Zitat Cox AJ, Hukins DWL, Davies KE, Irlam JC, Sutton TM (1987) An automated technique for in vitro assessment of susceptibility of urinary catheter materials to encrustation. Eng Med 16:37PubMedCrossRef Cox AJ, Hukins DWL, Davies KE, Irlam JC, Sutton TM (1987) An automated technique for in vitro assessment of susceptibility of urinary catheter materials to encrustation. Eng Med 16:37PubMedCrossRef
3.
Zurück zum Zitat Tunney MM, Bonner MC, Keane PF, Gorman SP (1996) Development of a model for assessment of biomaterial encrustation in the upper urinary tract. Biomaterials 17:1025–1029PubMedCrossRef Tunney MM, Bonner MC, Keane PF, Gorman SP (1996) Development of a model for assessment of biomaterial encrustation in the upper urinary tract. Biomaterials 17:1025–1029PubMedCrossRef
4.
Zurück zum Zitat Tunney MM, Keane PF, Jones DS, Gorman SP (1996) Comparative assessment of ureteral stent biomaterial encrustation. Biomaterials 17:1541–1546PubMedCrossRef Tunney MM, Keane PF, Jones DS, Gorman SP (1996) Comparative assessment of ureteral stent biomaterial encrustation. Biomaterials 17:1541–1546PubMedCrossRef
5.
Zurück zum Zitat Nedilko T, Paulose PA, Buchholz N, Knight MM (2011) Comparison of encrustation rates between ureteric metal stents and Double J stents. Eur Urol (Supp) 10:479CrossRef Nedilko T, Paulose PA, Buchholz N, Knight MM (2011) Comparison of encrustation rates between ureteric metal stents and Double J stents. Eur Urol (Supp) 10:479CrossRef
6.
Zurück zum Zitat Patel D, Maan Z, El-Husseiny T, Moraitis K, Junaid I, Buchholz N, Masood J (2011) Characterising stent symptoms associated with a segmental thermo-expandable metallic stent using a validated stent symptoms questionnaire. Curr Urol 5:72–78CrossRef Patel D, Maan Z, El-Husseiny T, Moraitis K, Junaid I, Buchholz N, Masood J (2011) Characterising stent symptoms associated with a segmental thermo-expandable metallic stent using a validated stent symptoms questionnaire. Curr Urol 5:72–78CrossRef
7.
Zurück zum Zitat Gilmore FB, Turiough MH, Jones DS, Gorman SP (2010) Validation of the CDC biofilm reactor as a dynamic model for assessment of encrustation formation on urological device materials. J Biomed Mat Res 93(1):128–140 Gilmore FB, Turiough MH, Jones DS, Gorman SP (2010) Validation of the CDC biofilm reactor as a dynamic model for assessment of encrustation formation on urological device materials. J Biomed Mat Res 93(1):128–140
8.
Zurück zum Zitat Jones DS, Djokic J, Gorman SP (2006) Characterization and optimization of experimented variables within a reproducible bladder encrustation model and in vitro evaluation of the efficacy of urease inhibitors for the prevention of medical device-related encrustations. J Biomed Mat Res 76:1–7CrossRef Jones DS, Djokic J, Gorman SP (2006) Characterization and optimization of experimented variables within a reproducible bladder encrustation model and in vitro evaluation of the efficacy of urease inhibitors for the prevention of medical device-related encrustations. J Biomed Mat Res 76:1–7CrossRef
Metadaten
Titel
In vitro encrustation of a semi-permanent polymer-covered nitinol ureter stent: an artificial urine model
verfasst von
Tabassum Shaheen
Thiaga Edirisinghe
Melissa Gabriel
Andreas Bourdoumis
Noor Buchholz
Martin Knight
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 3/2014
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-014-0652-5

Weitere Artikel der Ausgabe 3/2014

Urolithiasis 3/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.